Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3.

Xia T, O'Hara A, Araujo I, Barreto J, Carvalho E, Sapucaia JB, Ramos JC, Luz E, Pedroso C, Manrique M, Toomey NL, Brites C, Dittmer DP, Harrington WJ Jr.

Cancer Res. 2008 Mar 1;68(5):1436-42. doi: 10.1158/0008-5472.CAN-07-5126.

2.

A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia.

Qiu J, Cosmopoulos K, Pegtel M, Hopmans E, Murray P, Middeldorp J, Shapiro M, Thorley-Lawson DA.

PLoS Pathog. 2011 Aug;7(8):e1002193. doi: 10.1371/journal.ppat.1002193. Epub 2011 Aug 25.

3.

EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.

Ma J, Nie K, Redmond D, Liu Y, Elemento O, Knowles DM, Tam W.

Leukemia. 2016 Mar;30(3):594-604. doi: 10.1038/leu.2015.285. Epub 2015 Nov 4.

4.

A cluster of virus-encoded microRNAs accelerates acute systemic Epstein-Barr virus infection but does not significantly enhance virus-induced oncogenesis in vivo.

Wahl A, Linnstaedt SD, Esoda C, Krisko JF, Martinez-Torres F, Delecluse HJ, Cullen BR, Garcia JV.

J Virol. 2013 May;87(10):5437-46. doi: 10.1128/JVI.00281-13. Epub 2013 Mar 6.

5.

BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes.

Oudejans JJ, van den Brule AJ, Jiwa NM, de Bruin PC, Ossenkoppele GJ, van der Valk P, Walboomers JM, Meijer CJ.

Blood. 1995 Sep 1;86(5):1893-902.

6.

Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.

Amoroso R, Fitzsimmons L, Thomas WA, Kelly GL, Rowe M, Bell AI.

J Virol. 2011 Jan;85(2):996-1010. doi: 10.1128/JVI.01528-10. Epub 2010 Nov 10.

7.

A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus.

Feederle R, Linnstaedt SD, Bannert H, Lips H, Bencun M, Cullen BR, Delecluse HJ.

PLoS Pathog. 2011 Feb;7(2):e1001294. doi: 10.1371/journal.ppat.1001294. Epub 2011 Feb 17.

8.

Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.

Watanabe A, Maruo S, Ito T, Ito M, Katsumura KR, Takada K.

J Virol. 2010 Mar;84(6):2893-901. doi: 10.1128/JVI.01616-09. Epub 2009 Dec 30.

9.

Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells.

Yang HJ, Huang TJ, Yang CF, Peng LX, Liu RY, Yang GD, Chu QQ, Huang JL, Liu N, Huang HB, Zhu ZY, Qian CN, Huang BJ.

Virol J. 2013 Oct 26;10:314. doi: 10.1186/1743-422X-10-314.

10.

The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines.

Pratt ZL, Kuzembayeva M, Sengupta S, Sugden B.

Virology. 2009 Apr 10;386(2):387-97. doi: 10.1016/j.virol.2009.01.006. Epub 2009 Feb 12.

11.

EBV encoded miR-BHRF1-1 potentiates viral lytic replication by downregulating host p53 in nasopharyngeal carcinoma.

Li Z, Chen X, Li L, Liu S, Yang L, Ma X, Tang M, Bode AM, Dong Z, Sun L, Cao Y.

Int J Biochem Cell Biol. 2012 Feb;44(2):275-9. doi: 10.1016/j.biocel.2011.11.007. Epub 2011 Nov 17.

PMID:
22108199
12.

Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas.

Sakamoto K, Sekizuka T, Uehara T, Hishima T, Mine S, Fukumoto H, Sato Y, Hasegawa H, Kuroda M, Katano H.

Cancer Med. 2017 Mar;6(3):605-618. doi: 10.1002/cam4.1006. Epub 2017 Feb 9.

13.

Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas.

Ramakrishnan R, Donahue H, Garcia D, Tan J, Shimizu N, Rice AP, Ling PD.

PLoS One. 2011;6(11):e27271. doi: 10.1371/journal.pone.0027271. Epub 2011 Nov 10.

14.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
15.

Biogenesis of Epstein-Barr virus microRNAs.

Kim DN, Lee SK.

Mol Cell Biochem. 2012 Jun;365(1-2):203-10. doi: 10.1007/s11010-012-1261-7. Epub 2012 Feb 18.

PMID:
22350759
16.

Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.

Niedobitek G, Agathanggelou A, Rowe M, Jones EL, Jones DB, Turyaguma P, Oryema J, Wright DH, Young LS.

Blood. 1995 Jul 15;86(2):659-65.

17.
18.

EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.

Riley KJ, Rabinowitz GS, Yario TA, Luna JM, Darnell RB, Steitz JA.

EMBO J. 2012 May 2;31(9):2207-21. doi: 10.1038/emboj.2012.63. Epub 2012 Mar 30.

19.

MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.

Jung YJ, Choi H, Kim H, Lee SK.

J Virol. 2014 Aug;88(16):9027-37. doi: 10.1128/JVI.00721-14. Epub 2014 Jun 4.

20.

Azidothymidine and interferon-alpha induce apoptosis in herpesvirus-associated lymphomas.

Lee RK, Cai JP, Deyev V, Gill PS, Cabral L, Wood C, Agarwal RP, Xia W, Boise LH, Podack E, Harrington WJ Jr.

Cancer Res. 1999 Nov 1;59(21):5514-20.

Supplemental Content

Support Center